Novo Nordisk Foundation Female Heart β Clinical Mechanistic Grant Programme 2026
Deadline: Mar 19, 2026
other
3β5 years (duration)
partially funded
Finland, Sweden, Switzerland, Denmark, Iceland, and 1 others
Opportunity Overview
π About Novo Nordisk Foundation Female Heart β Clinical Mechanistic Grant Programme
The Novo Nordisk Foundation (NNF) has launched this initiative to address the critical research gap in female cardiovascular health. Historically, heart disease research has been male-centric; this grant specifically targets the mechanistic driversβthe biological and physiological βhow and whyββbehind sex-specific variations in heart disease.
π° Benefits
- Total Pool: Up to DKK 75 million.
β Eligibility Criteria
Lead (Main) Applicant Requirements:
- Must be an established researcher (e.g., Associate Professor, Professor, or Senior Scientist).
- Must be anchored at a university, hospital, or non-profit research institution in a Nordic country (Denmark, Sweden, Norway, Finland, or Iceland).
- Must have their own salary guaranteed by the host institution for the full project duration (3β5 years).
Co-Applicant Requirements:
- Must be based at a non-profit institution within the EEA, United Kingdom, or Switzerland.
- Mandatory Internationality: At least one co-applicant must be in a different country than the Main Applicant.
- Must contribute significantly to the science and receive a substantial portion of the budget.
π Application Date and Process
Interested applicants can apply through the application website. Ensure all requirements are met before submission.
β° Application Deadline
19 March, 2026
π Scholarship Application Portal
- View details of the Novo Nordisk Foundation Female Heart β Clinical Mechanistic Grant Programme here.
- Apply for the grant here.
This grant prioritizes cross-border European collaboration and aims to advance research in female cardiovascular health. Don't miss this opportunity to contribute to groundbreaking research!
Benefits
- Total Pool: Up to DKK 75 million.







